search
Back to results

Should Palatine Tonsils be Included in the Oropharyngeal Swab for SARS-CoV-2 Molecular Testing?

Primary Purpose

SARS-CoV Infection, Coronavirus, Corona Virus Infection

Status
Recruiting
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
An Oropharyngeal swab
Sponsored by
Rigshospitalet, Denmark
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for SARS-CoV Infection

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: citizens referred for outpatient testing for COVID-19 in Valby and Hillerød COVID-19 TestCenter. Exclusion Criteria: Age under 18 years neck breathers (tracheostomy/laryngectomy patients)

Sites / Locations

  • Hillerød Covid-19 TestcenterRecruiting
  • ValbyRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Oropharyngeal swab only including the posterior oropharyngeal wall

Oropharyngeal swab including the posterior oropharyngeal wall and both palatine tonsils

Arm Description

An Oropharyngeal swab is performed with the collection of specimens from the posterior oropharyngeal wall only

An Oropharyngeal swab is performed with the collection of specimens from the posterior oropharyngeal wall and both palatine tonsils

Outcomes

Primary Outcome Measures

RT-PCR results
The detection rate of SARS-CoV-2 RNA

Secondary Outcome Measures

Sycle threshold (Ct)
SARS-CoV-2 RT-PCR cycle threshold (Ct) values
Inconclusive tests
Number of inconclusive RT-PCR tests results
Test discomfort
Self reported on a 11-point NRS-scale from 0 - 10 (with 10 being the worst imaginable discomfort)
Development of COVID-19 disease after testing
Online questionare about symptoms send by email
Test accuracy between healthcare workers
SARS-CoV-2 detection rate for each healthcare worker
Participants oropharynx anatomy
Mallampati Score of participants

Full Information

First Posted
November 3, 2022
Last Updated
January 10, 2023
Sponsor
Rigshospitalet, Denmark
search

1. Study Identification

Unique Protocol Identification Number
NCT05611203
Brief Title
Should Palatine Tonsils be Included in the Oropharyngeal Swab for SARS-CoV-2 Molecular Testing?
Official Title
Molecular Detection of SARS-CoV-2 From Oropharyngeal Swabs Performed With or Without Specimen Collection From the Palatine Tonsils - a Multicenter Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 10, 2022 (Actual)
Primary Completion Date
January 30, 2023 (Anticipated)
Study Completion Date
March 2, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rigshospitalet, Denmark

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Citizens who undergo testing for COVID-19 at one of two Testcenters in Copenhagen Captial Region will be invited to participate in the study. The participants will be randomized to either an oropharyngeal swap including the palatine tonsils OR an oropharyngeal swap without the palatine tonsils for SARS-CoV-2 testing. The swabs will be sent to the clinical microbiology laboratory for SARS-CoV-2 detection using RT-PCR. The diagnostic accuracy and SARS-CoV-2 viral load will be compared. The participants will be asked to complete a questionnaire regarding their symptoms.
Detailed Description
We will include citizens referred for outpatient testing for COVID-19 who will be offered to participante in the study on a volunteer basis. Participants are all volunteers, who are attending the test facilities to obtain a PCR test. Participants are required to provide oral and written informed consent to participate before entering the study. The inclusion criterion is 18 years or more of age. Exclusion criteria are neck breathers (tracheostomy/laryngectomy patients). The participants will be randomized to either an oropharyngeal swap including the palatine tonsils OR an oropharyngeal swap without the palatine tonsils for SARS-CoV-2 testing. The swabs will be sent to the clinical microbiology laboratory for SARS-CoV-2 detection using RT-PCR as usual. The diagnostic accuracy and SARS-CoV-2 viral load will be compared using independent t-test. The participants will be asked to complete a questionnaire regarding their symptoms and the number of sick days. All data will be documented on-site in a secure web database (REDCap). The primary outcome will be reported as: • SARS-CoV-2 RNA by RT-PCR test result (positive, negative, inconclusive) The secondary outcome will be reported as: SARS-CoV-2 RT-PCR cycle threshold (Ct) value Test discomfort on a 11-point NRS-scale Development of COVID-19 disease after testing SARS-CoV-2 detection rate for each healthcare worker Mallampati Score of participants being tested

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
SARS-CoV Infection, Coronavirus, Corona Virus Infection

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1000 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Oropharyngeal swab only including the posterior oropharyngeal wall
Arm Type
Experimental
Arm Description
An Oropharyngeal swab is performed with the collection of specimens from the posterior oropharyngeal wall only
Arm Title
Oropharyngeal swab including the posterior oropharyngeal wall and both palatine tonsils
Arm Type
Experimental
Arm Description
An Oropharyngeal swab is performed with the collection of specimens from the posterior oropharyngeal wall and both palatine tonsils
Intervention Type
Procedure
Intervention Name(s)
An Oropharyngeal swab
Intervention Description
An Oropharyngeal swab performed for diagnostic purposes
Primary Outcome Measure Information:
Title
RT-PCR results
Description
The detection rate of SARS-CoV-2 RNA
Time Frame
Day 1
Secondary Outcome Measure Information:
Title
Sycle threshold (Ct)
Description
SARS-CoV-2 RT-PCR cycle threshold (Ct) values
Time Frame
Day 1
Title
Inconclusive tests
Description
Number of inconclusive RT-PCR tests results
Time Frame
Day 1
Title
Test discomfort
Description
Self reported on a 11-point NRS-scale from 0 - 10 (with 10 being the worst imaginable discomfort)
Time Frame
Day 1
Title
Development of COVID-19 disease after testing
Description
Online questionare about symptoms send by email
Time Frame
1 month
Title
Test accuracy between healthcare workers
Description
SARS-CoV-2 detection rate for each healthcare worker
Time Frame
Day 1
Title
Participants oropharynx anatomy
Description
Mallampati Score of participants
Time Frame
Day 1

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: citizens referred for outpatient testing for COVID-19 in Valby and Hillerød COVID-19 TestCenter. Exclusion Criteria: Age under 18 years neck breathers (tracheostomy/laryngectomy patients)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Tobias Todsen, MD, PhD
Phone
+45 35466008
Email
tobias.todsen@regionh.dk
Facility Information:
Facility Name
Hillerød Covid-19 Testcenter
City
Copenhagen
State/Province
Hillerød
ZIP/Postal Code
3400
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tobias Todsen, MD, PhD
Facility Name
Valby
City
Copenhagen
ZIP/Postal Code
2500
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tobias Todsen, MD, PhD

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
Not decided

Learn more about this trial

Should Palatine Tonsils be Included in the Oropharyngeal Swab for SARS-CoV-2 Molecular Testing?

We'll reach out to this number within 24 hrs